Skip to content
20-F

Annual Report (Foreign)

AC IMMUNE SA ACIU

0001558370-25-002855

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 100.41M sh
Current Liabilities FY 2024 · Dec 31, 2023 13.58M
Total Liabilities FY 2024 · Dec 31, 2023 22.17M
Current Assets FY 2024 · Dec 31, 2023 125.15M
Total Assets FY 2024 · Dec 31, 2023 182.81M
Shares Diluted FY 2024 · Dec 31, 2022 83.55M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −73.57M
Eps Diluted FY 2024 · Dec 31, 2022 −0.85
Eps Basic FY 2024 · Dec 31, 2022 −0.85
Rd Expense FY 2024 · Dec 31, 2022 60.34M
Net Income FY 2024 · Dec 31, 2022 −70.75M
Operating Income FY 2024 · Dec 31, 2022 −70.85M
Revenue FY 2024 · Dec 31, 2022 3.94M
Cash And Equivalents FY 2024 · Dec 31, 2021 82.22M
Stockholders Equity FY 2024 · Dec 31, 2021 231.98M